脂肪肝耻辱的神话:证据显示了什么?

IF 3.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
{"title":"脂肪肝耻辱的神话:证据显示了什么?","authors":"","doi":"10.1016/j.aohep.2024.101535","DOIUrl":null,"url":null,"abstract":"<div><p>Recent efforts to reclassify non-alcoholic fatty liver disease (NAFLD) as metabolic dysfunction-associated fatty liver disease (MAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD) are intended to divert attention to the metabolic basis of the disease rather than to alcohol consumption. This reclassification recognizes the role of obesity, sedentary lifestyles and poor dietary habits in the development of the disease, leading to a better understanding of its etiology. Nevertheless, the transition has posed its own challenges, particularly with regard to communication between patient and healthcare professional. Many healthcare professionals report difficulty in explaining the nuanced concepts, especially the term \"steatosis\". In addition, the change in terminology has not yet removed the stigma, with ongoing debates about the appropriateness of the terms \"fatty\" and \"steatotic\". Surveys suggest that while \"obesity\" may be perceived as more stigmatizing, the medical term \"steatotic liver disease\" is not considered as stigmatizing, indicating a disconnect in perceptions between healthcare professionals and patients.</p></div>","PeriodicalId":7979,"journal":{"name":"Annals of hepatology","volume":null,"pages":null},"PeriodicalIF":3.7000,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1665268124003296/pdfft?md5=7ee64d135d5dc70959f6131b8c271544&pid=1-s2.0-S1665268124003296-main.pdf","citationCount":"0","resultStr":"{\"title\":\"The myth of the stigma of fatty liver: What does the evidence show?\",\"authors\":\"\",\"doi\":\"10.1016/j.aohep.2024.101535\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Recent efforts to reclassify non-alcoholic fatty liver disease (NAFLD) as metabolic dysfunction-associated fatty liver disease (MAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD) are intended to divert attention to the metabolic basis of the disease rather than to alcohol consumption. This reclassification recognizes the role of obesity, sedentary lifestyles and poor dietary habits in the development of the disease, leading to a better understanding of its etiology. Nevertheless, the transition has posed its own challenges, particularly with regard to communication between patient and healthcare professional. Many healthcare professionals report difficulty in explaining the nuanced concepts, especially the term \\\"steatosis\\\". In addition, the change in terminology has not yet removed the stigma, with ongoing debates about the appropriateness of the terms \\\"fatty\\\" and \\\"steatotic\\\". Surveys suggest that while \\\"obesity\\\" may be perceived as more stigmatizing, the medical term \\\"steatotic liver disease\\\" is not considered as stigmatizing, indicating a disconnect in perceptions between healthcare professionals and patients.</p></div>\",\"PeriodicalId\":7979,\"journal\":{\"name\":\"Annals of hepatology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2024-08-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1665268124003296/pdfft?md5=7ee64d135d5dc70959f6131b8c271544&pid=1-s2.0-S1665268124003296-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of hepatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1665268124003296\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of hepatology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1665268124003296","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

最近,非酒精性脂肪肝(NAFLD)被重新分类为代谢功能障碍相关性脂肪肝(MAFLD)和代谢功能障碍相关性脂肪肝(MASLD),目的是将人们的注意力转移到该疾病的代谢基础上,而不是酒精消费上。这一重新分类承认了肥胖、久坐不动的生活方式和不良饮食习惯在疾病发生中的作用,从而使人们对其病因有了更好的了解。然而,这一转变也带来了挑战,尤其是在患者与医护人员的沟通方面。许多医护人员表示很难解释其中的微妙概念,尤其是 "脂肪变性 "一词。此外,术语的变化尚未消除耻辱感,关于 "脂肪 "和 "脂肪变性 "这两个术语是否恰当的争论仍在继续。调查显示,虽然 "肥胖 "可能被认为更具有污名化,但医学术语 "脂肪肝 "却不被认为具有污名化,这表明医护人员和患者之间的认知存在脱节。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The myth of the stigma of fatty liver: What does the evidence show?

Recent efforts to reclassify non-alcoholic fatty liver disease (NAFLD) as metabolic dysfunction-associated fatty liver disease (MAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD) are intended to divert attention to the metabolic basis of the disease rather than to alcohol consumption. This reclassification recognizes the role of obesity, sedentary lifestyles and poor dietary habits in the development of the disease, leading to a better understanding of its etiology. Nevertheless, the transition has posed its own challenges, particularly with regard to communication between patient and healthcare professional. Many healthcare professionals report difficulty in explaining the nuanced concepts, especially the term "steatosis". In addition, the change in terminology has not yet removed the stigma, with ongoing debates about the appropriateness of the terms "fatty" and "steatotic". Surveys suggest that while "obesity" may be perceived as more stigmatizing, the medical term "steatotic liver disease" is not considered as stigmatizing, indicating a disconnect in perceptions between healthcare professionals and patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Annals of hepatology
Annals of hepatology 医学-胃肠肝病学
CiteScore
7.90
自引率
2.60%
发文量
183
审稿时长
4-8 weeks
期刊介绍: Annals of Hepatology publishes original research on the biology and diseases of the liver in both humans and experimental models. Contributions may be submitted as regular articles. The journal also publishes concise reviews of both basic and clinical topics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信